UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder

The pharmacogenomics journal, 2013-08, Vol.13 (4), p.354-358

2013

Link zum Volltext

Verfügbarkeit prüfen

P.2.f.011 Serum levels of BDNF, BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine (MRT) with major depressive disorder (MDD)

European neuropsychopharmacology, 2013-10, Vol.23, p.S402-S402

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls

European psychiatry, 2011-01, Vol.26 (1), p.57-63

2011

Link zum Volltext

Verfügbarkeit prüfen

P.2.a.003 Three polymorphisms of endothelial nitric oxide synthase (eNOS) gene and plasma NO3 levels

European neuropsychopharmacology, 2010-08, Vol.20, p.S334-S335

2010

Link zum Volltext

Verfügbarkeit prüfen

P.2.c.001 Adding an atypical antipsychotic drug induced a rapid increase of plasma BDNF levels in refractory depression

European neuropsychopharmacology, 2010, Vol.20, p.S367-S368

2010

Link zum Volltext

Verfügbarkeit prüfen

P.2.a.009 Nonadherence to paroxetine; comparison between early-remitters and late-remitters

European neuropsychopharmacology, 2010, Vol.20, p.S338-S338

2010

Link zum Volltext

Verfügbarkeit prüfen

P.2.c.002 A heterogeneity of depression: views from dynamics of blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF)

European neuropsychopharmacology, 2008, Vol.18, p.S325-S326

2008

Link zum Volltext

Verfügbarkeit prüfen

GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder

Journal of affective disorders, 2012-12, Vol.142 (1), p.315-322

2012

Link zum Volltext

Verfügbarkeit prüfen

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study

Neuropsychiatric disease and treatment, 2014-06, Vol.10 (default), p.1183-1190

2014

Link zum Volltext

Verfügbarkeit prüfen

Plasma Levels of Metabolites of Catecholamine in Nicotine-Dependent Patients Treated With Varenicline

Nicotine & tobacco research, 2012-04, Vol.14 (4), p.486-489

2012

Link zum Volltext

Verfügbarkeit prüfen

The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy

The journal of ECT, 2012-03, Vol.28 (1), p.56

2012

Link zum Volltext

Verfügbarkeit prüfen

P.2.a.003 Three polymorphisms of endothelial nitric oxide synthase (eNOS) gene and plasma NO 3 levels

European neuropsychopharmacology, 2010, Vol.20, p.S334-S335

2010

Link zum Volltext

Verfügbarkeit prüfen

Grapefruit juice inhibits the pharmacokinetics of sertraline

The international journal of neuropsychopharmacology, 2008-07, Vol.11, p.132

2008

Link zum Volltext

Verfügbarkeit prüfen

Increase of blood levels of BDNF and HVA are associated with its clinical efficacy in depressed patients

The international journal of neuropsychopharmacology, 2008-07, Vol.11, p.116

2008

Link zum Volltext

Verfügbarkeit prüfen

Serum brain derived neurotrophic factor is associated with psychiatric symptoms in neuropsychiatric systemic lupus erythematosus

The international journal of neuropsychopharmacology, 2008-07, Vol.11, p.93

2008

Link zum Volltext

Verfügbarkeit prüfen

Hikikomori as a possible clinical term in psychiatry: a questionnaire survey

BMC psychiatry, 2012-10, Vol.12 (1), p.169-169, Article 169

2012

Link zum Volltext

Verfügbarkeit prüfen

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia

Neuropsychiatric disease and treatment, 2012-01, Vol.8 (default), p.119-122

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder

P.2.f.011 Serum levels of BDNF, BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine (MRT) with major depressive disorder (MDD)

Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls

P.2.a.003 Three polymorphisms of endothelial nitric oxide synthase (eNOS) gene and plasma NO3 levels

P.2.c.001 Adding an atypical antipsychotic drug induced a rapid increase of plasma BDNF levels in refractory depression

P.2.a.009 Nonadherence to paroxetine; comparison between early-remitters and late-remitters

P.2.c.002 A heterogeneity of depression: views from dynamics of blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF)

GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study

Plasma Levels of Metabolites of Catecholamine in Nicotine-Dependent Patients Treated With Varenicline

The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy

P.2.a.003 Three polymorphisms of endothelial nitric oxide synthase (eNOS) gene and plasma NO 3 levels

Grapefruit juice inhibits the pharmacokinetics of sertraline

Increase of blood levels of BDNF and HVA are associated with its clinical efficacy in depressed patients

Serum brain derived neurotrophic factor is associated with psychiatric symptoms in neuropsychiatric systemic lupus erythematosus

Hikikomori as a possible clinical term in psychiatry: a questionnaire survey

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia

Suchergebnisse filtern